SilcsBio, Helix BioStructures Launch Partnership to Collaborate in Pharmaceutical Drug Design Opportunities

By |2022-08-29T16:19:31+00:00August 29th, 2022|Latest News, News|

SilcsBio, an Early Charm drug design portfolio company, today announced the launch of a partnership with Helix BioStructures to tap mutual areas of expertise in drug design and spur new opportunities for pharmaceutical and research organizations.